Global Ramucirumab Market Growth 2025-2031

December 2025 | 83 pages | ID: G7C7E24F5A9EN
LP Information

Abstracts

The global Ramucirumab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Ramucirumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Ramucirumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Ramucirumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Ramucirumab players cover Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Ramucirumab Industry Forecast” looks at past sales and reviews total world Ramucirumab sales in 2024, providing a comprehensive analysis by region and market sector of projected Ramucirumab sales for 2025 through 2031. With Ramucirumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ramucirumab industry.

This Insight Report provides a comprehensive analysis of the global Ramucirumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ramucirumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ramucirumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ramucirumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ramucirumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Ramucirumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100mg/Box
• 500mg/Box

Segmentation by Application:

• Advanced Gastric Cancer
• GEJ Adenocarcinoma
• Non-small Cell Lung Carcinoma
• Metastatic Colorectal Cancer (mCRC)
• Hepatocellular Carcinoma (HCC)

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Eli Lilly

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ramucirumab market?

What factors are driving Ramucirumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ramucirumab market opportunities vary by end market size?

How does Ramucirumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ramucirumab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Ramucirumab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Ramucirumab by Country/Region, 2020, 2024 & 2031
2.2 Ramucirumab Segment by Type
  2.2.1 100mg/Box
  2.2.2 500mg/Box
2.3 Ramucirumab Sales by Type
  2.3.1 Global Ramucirumab Sales Market Share by Type (2020-2025)
  2.3.2 Global Ramucirumab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Ramucirumab Sale Price by Type (2020-2025)
2.4 Ramucirumab Segment by Application
  2.4.1 Advanced Gastric Cancer
  2.4.2 GEJ Adenocarcinoma
  2.4.3 Non-small Cell Lung Carcinoma
  2.4.4 Metastatic Colorectal Cancer (mCRC)
  2.4.5 Hepatocellular Carcinoma (HCC)
2.5 Ramucirumab Sales by Application
  2.5.1 Global Ramucirumab Sale Market Share by Application (2020-2025)
  2.5.2 Global Ramucirumab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Ramucirumab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Ramucirumab Breakdown Data by Company
  3.1.1 Global Ramucirumab Annual Sales by Company (2020-2025)
  3.1.2 Global Ramucirumab Sales Market Share by Company (2020-2025)
3.2 Global Ramucirumab Annual Revenue by Company (2020-2025)
  3.2.1 Global Ramucirumab Revenue by Company (2020-2025)
  3.2.2 Global Ramucirumab Revenue Market Share by Company (2020-2025)
3.3 Global Ramucirumab Sale Price by Company
3.4 Key Manufacturers Ramucirumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Ramucirumab Product Location Distribution
  3.4.2 Players Ramucirumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR RAMUCIRUMAB BY GEOGRAPHIC REGION

4.1 World Historic Ramucirumab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Ramucirumab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Ramucirumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Ramucirumab Market Size by Country/Region (2020-2025)
  4.2.1 Global Ramucirumab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Ramucirumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ramucirumab Sales Growth
4.4 APAC Ramucirumab Sales Growth
4.5 Europe Ramucirumab Sales Growth
4.6 Middle East & Africa Ramucirumab Sales Growth

5 AMERICAS

5.1 Americas Ramucirumab Sales by Country
  5.1.1 Americas Ramucirumab Sales by Country (2020-2025)
  5.1.2 Americas Ramucirumab Revenue by Country (2020-2025)
5.2 Americas Ramucirumab Sales by Type (2020-2025)
5.3 Americas Ramucirumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ramucirumab Sales by Region
  6.1.1 APAC Ramucirumab Sales by Region (2020-2025)
  6.1.2 APAC Ramucirumab Revenue by Region (2020-2025)
6.2 APAC Ramucirumab Sales by Type (2020-2025)
6.3 APAC Ramucirumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Ramucirumab by Country
  7.1.1 Europe Ramucirumab Sales by Country (2020-2025)
  7.1.2 Europe Ramucirumab Revenue by Country (2020-2025)
7.2 Europe Ramucirumab Sales by Type (2020-2025)
7.3 Europe Ramucirumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ramucirumab by Country
  8.1.1 Middle East & Africa Ramucirumab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Ramucirumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Ramucirumab Sales by Type (2020-2025)
8.3 Middle East & Africa Ramucirumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ramucirumab
10.3 Manufacturing Process Analysis of Ramucirumab
10.4 Industry Chain Structure of Ramucirumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Ramucirumab Distributors
11.3 Ramucirumab Customer

12 WORLD FORECAST REVIEW FOR RAMUCIRUMAB BY GEOGRAPHIC REGION

12.1 Global Ramucirumab Market Size Forecast by Region
  12.1.1 Global Ramucirumab Forecast by Region (2026-2031)
  12.1.2 Global Ramucirumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Ramucirumab Forecast by Type (2026-2031)
12.7 Global Ramucirumab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Information
  13.1.2 Eli Lilly Ramucirumab Product Portfolios and Specifications
  13.1.3 Eli Lilly Ramucirumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Eli Lilly Main Business Overview
  13.1.5 Eli Lilly Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Ramucirumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Ramucirumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg/Box
Table 4. Major Players of 500mg/Box
Table 5. Global Ramucirumab Sales by Type (2020-2025) & (K Box)
Table 6. Global Ramucirumab Sales Market Share by Type (2020-2025)
Table 7. Global Ramucirumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Ramucirumab Revenue Market Share by Type (2020-2025)
Table 9. Global Ramucirumab Sale Price by Type (2020-2025) & (USD/Box)
Table 10. Global Ramucirumab Sale by Application (2020-2025) & (K Box)
Table 11. Global Ramucirumab Sale Market Share by Application (2020-2025)
Table 12. Global Ramucirumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Ramucirumab Revenue Market Share by Application (2020-2025)
Table 14. Global Ramucirumab Sale Price by Application (2020-2025) & (USD/Box)
Table 15. Global Ramucirumab Sales by Company (2020-2025) & (K Box)
Table 16. Global Ramucirumab Sales Market Share by Company (2020-2025)
Table 17. Global Ramucirumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Ramucirumab Revenue Market Share by Company (2020-2025)
Table 19. Global Ramucirumab Sale Price by Company (2020-2025) & (USD/Box)
Table 20. Key Manufacturers Ramucirumab Producing Area Distribution and Sales Area
Table 21. Players Ramucirumab Products Offered
Table 22. Ramucirumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ramucirumab Sales by Geographic Region (2020-2025) & (K Box)
Table 26. Global Ramucirumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Ramucirumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Ramucirumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Ramucirumab Sales by Country/Region (2020-2025) & (K Box)
Table 30. Global Ramucirumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Ramucirumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Ramucirumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Ramucirumab Sales by Country (2020-2025) & (K Box)
Table 34. Americas Ramucirumab Sales Market Share by Country (2020-2025)
Table 35. Americas Ramucirumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Ramucirumab Sales by Type (2020-2025) & (K Box)
Table 37. Americas Ramucirumab Sales by Application (2020-2025) & (K Box)
Table 38. APAC Ramucirumab Sales by Region (2020-2025) & (K Box)
Table 39. APAC Ramucirumab Sales Market Share by Region (2020-2025)
Table 40. APAC Ramucirumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Ramucirumab Sales by Type (2020-2025) & (K Box)
Table 42. APAC Ramucirumab Sales by Application (2020-2025) & (K Box)
Table 43. Europe Ramucirumab Sales by Country (2020-2025) & (K Box)
Table 44. Europe Ramucirumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Ramucirumab Sales by Type (2020-2025) & (K Box)
Table 46. Europe Ramucirumab Sales by Application (2020-2025) & (K Box)
Table 47. Middle East & Africa Ramucirumab Sales by Country (2020-2025) & (K Box)
Table 48. Middle East & Africa Ramucirumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Ramucirumab Sales by Type (2020-2025) & (K Box)
Table 50. Middle East & Africa Ramucirumab Sales by Application (2020-2025) & (K Box)
Table 51. Key Market Drivers & Growth Opportunities of Ramucirumab
Table 52. Key Market Challenges & Risks of Ramucirumab
Table 53. Key Industry Trends of Ramucirumab
Table 54. Ramucirumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ramucirumab Distributors List
Table 57. Ramucirumab Customer List
Table 58. Global Ramucirumab Sales Forecast by Region (2026-2031) & (K Box)
Table 59. Global Ramucirumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Ramucirumab Sales Forecast by Country (2026-2031) & (K Box)
Table 61. Americas Ramucirumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Ramucirumab Sales Forecast by Region (2026-2031) & (K Box)
Table 63. APAC Ramucirumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Ramucirumab Sales Forecast by Country (2026-2031) & (K Box)
Table 65. Europe Ramucirumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Ramucirumab Sales Forecast by Country (2026-2031) & (K Box)
Table 67. Middle East & Africa Ramucirumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Ramucirumab Sales Forecast by Type (2026-2031) & (K Box)
Table 69. Global Ramucirumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Ramucirumab Sales Forecast by Application (2026-2031) & (K Box)
Table 71. Global Ramucirumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Eli Lilly Basic Information, Ramucirumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Eli Lilly Ramucirumab Product Portfolios and Specifications
Table 74. Eli Lilly Ramucirumab Sales (K Box), Revenue ($ Million), Price (USD/Box) and Gross Margin (2020-2025)
Table 75. Eli Lilly Main Business
Table 76. Eli Lilly Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Ramucirumab
Figure 2. Ramucirumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ramucirumab Sales Growth Rate 2020-2031 (K Box)
Figure 7. Global Ramucirumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Ramucirumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Ramucirumab Sales Market Share by Country/Region (2024)
Figure 10. Ramucirumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg/Box
Figure 12. Product Picture of 500mg/Box
Figure 13. Global Ramucirumab Sales Market Share by Type in 2025
Figure 14. Global Ramucirumab Revenue Market Share by Type (2020-2025)
Figure 15. Ramucirumab Consumed in Advanced Gastric Cancer
Figure 16. Global Ramucirumab Market: Advanced Gastric Cancer (2020-2025) & (K Box)
Figure 17. Ramucirumab Consumed in GEJ Adenocarcinoma
Figure 18. Global Ramucirumab Market: GEJ Adenocarcinoma (2020-2025) & (K Box)
Figure 19. Ramucirumab Consumed in Non-small Cell Lung Carcinoma
Figure 20. Global Ramucirumab Market: Non-small Cell Lung Carcinoma (2020-2025) & (K Box)
Figure 21. Ramucirumab Consumed in Metastatic Colorectal Cancer (mCRC)
Figure 22. Global Ramucirumab Market: Metastatic Colorectal Cancer (mCRC) (2020-2025) & (K Box)
Figure 23. Ramucirumab Consumed in Hepatocellular Carcinoma (HCC)
Figure 24. Global Ramucirumab Market: Hepatocellular Carcinoma (HCC) (2020-2025) & (K Box)
Figure 25. Global Ramucirumab Sale Market Share by Application (2024)
Figure 26. Global Ramucirumab Revenue Market Share by Application in 2025
Figure 27. Ramucirumab Sales by Company in 2025 (K Box)
Figure 28. Global Ramucirumab Sales Market Share by Company in 2025
Figure 29. Ramucirumab Revenue by Company in 2025 ($ millions)
Figure 30. Global Ramucirumab Revenue Market Share by Company in 2025
Figure 31. Global Ramucirumab Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Ramucirumab Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Ramucirumab Sales 2020-2025 (K Box)
Figure 34. Americas Ramucirumab Revenue 2020-2025 ($ millions)
Figure 35. APAC Ramucirumab Sales 2020-2025 (K Box)
Figure 36. APAC Ramucirumab Revenue 2020-2025 ($ millions)
Figure 37. Europe Ramucirumab Sales 2020-2025 (K Box)
Figure 38. Europe Ramucirumab Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Ramucirumab Sales 2020-2025 (K Box)
Figure 40. Middle East & Africa Ramucirumab Revenue 2020-2025 ($ millions)
Figure 41. Americas Ramucirumab Sales Market Share by Country in 2025
Figure 42. Americas Ramucirumab Revenue Market Share by Country (2020-2025)
Figure 43. Americas Ramucirumab Sales Market Share by Type (2020-2025)
Figure 44. Americas Ramucirumab Sales Market Share by Application (2020-2025)
Figure 45. United States Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Ramucirumab Sales Market Share by Region in 2025
Figure 50. APAC Ramucirumab Revenue Market Share by Region (2020-2025)
Figure 51. APAC Ramucirumab Sales Market Share by Type (2020-2025)
Figure 52. APAC Ramucirumab Sales Market Share by Application (2020-2025)
Figure 53. China Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 57. India Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Ramucirumab Sales Market Share by Country in 2025
Figure 61. Europe Ramucirumab Revenue Market Share by Country (2020-2025)
Figure 62. Europe Ramucirumab Sales Market Share by Type (2020-2025)
Figure 63. Europe Ramucirumab Sales Market Share by Application (2020-2025)
Figure 64. Germany Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 65. France Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Ramucirumab Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Ramucirumab Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Ramucirumab Sales Market Share by Application (2020-2025)
Figure 72. Egypt Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Ramucirumab Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Ramucirumab in 2025
Figure 78. Manufacturing Process Analysis of Ramucirumab
Figure 79. Industry Chain Structure of Ramucirumab
Figure 80. Channels of Distribution
Figure 81. Global Ramucirumab Sales Market Forecast by Region (2026-2031)
Figure 82. Global Ramucirumab Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Ramucirumab Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Ramucirumab Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Ramucirumab Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Ramucirumab Revenue Market Share Forecast by Application (2026-2031)